Xenon Pharmaceuticals Inc (XENE)
Health Care – PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 370
- Market Cap
- $6.1B
About Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
SentiSense also tracks daily options readings for Xenon Pharmaceuticals Inc: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Xenon Pharmaceuticals Inc stock analysis, sentiment tracking, and market intelligence on SentiSense.